Brendan Hannah
Director of Finance/CFO chez QUINCE THERAPEUTICS, INC.
Fortune : 213 648 $ au 31/03/2024
Profil
Brendan Hannah is currently the COO, Chief Financial & Accounting Officer at Quince Therapeutics, Inc. and also holds the position of Chief Operating Officer at Novosteo, Inc. Previously, he worked as the Director of Business Development at Cidara Therapeutics, Inc. and as the Chief Business Officer at Neuroptika, Inc. Mr. Hannah obtained an MBA from the University of California.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2024 | 201 555 ( 0,47% ) | 213 648 $ | 31/03/2024 |
Postes actifs de Brendan Hannah
| Sociétés | Poste | Début |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director of Finance/CFO | 16/03/2023 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Chief Operating Officer | - |
Anciens postes connus de Brendan Hannah
| Sociétés | Poste | Fin |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2016 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Brendan Hannah
| University of California | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CIDARA THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Neuroptika, Inc. operates as biotechnology company which develops drugs for eye diseases and nerves regeneration. The company was founded by Chiho Fukiage and in November 2018 and is headquartered in Cambridge, MA. | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
